Skip to main content

Table 1 Clinical characteristic of the patients with inflammatory bowel disease

From: Imbalance of tissue inhibitors of metalloproteinases (TIMP) – 1 and – 4 serum levels, in patients with inflammatory bowel disease

 

UC

CD

Patients no

53

52

Mean age ± SD (range), years

49.8 ± 13.9 (20–79)

36.6 ± 13.6 (17–69)

Mean duration of disease ± SD (range), months

85.9 ± 81.8 (1–348)

72.4 ± 68.6 (1–388)

Male

30

21

Female

23

31

Current smokers

5

32

Ex smokers

20

2

Never smokers

28

18

Disease extent (UC)

  

   Proctitis

10

 

   Left-sided colitis

15

 

   Extensive colitis

28

 

Disease location (CD)

  

   Ileum

 

17

   Colon

 

4

   Ileum + colon

 

31

Disease behavior (CD)

  

   Inflammatory

 

32

   Strictrurizing

 

8

   Penetrating

 

12

Active disease

22

17

Inactive disease

31

35

Extraintestinal manifestations

24

29

Current treatment*

  

   5-ASA

51

51

   Steroids

28

43

   Enemas (5-ASA and/or steroids)

27

5

   Immunosuppressive agents

13

21

   Metronidazole

11

28

   Infliximab

4

15

   Parenteral nutrition

2

1

  1. *Some patients received > 1 drug.